Zastrow S - Search Results

1

Evaluation of polymorphisms in angiogenesis-related genes as predictive and prognostic markers for sunitinib-treated metastatic renal cell carcinoma patients.

Dornbusch J, Walter M, Gottschalk A, Obaje A, Junker K, Ohlmann CH, Meinhardt M, Zacharis A, Zastrow S, Schoffer O, Grimm MO, Klug SJ, Wirth MP, Fuessel S. Dornbusch J, et al. Among authors: zastrow s. J Cancer Res Clin Oncol. 2016 Jun;142(6):1171-82. doi: 10.1007/s00432-016-2137-0. Epub 2016 Mar 3. J Cancer Res Clin Oncol. 2016. PMID: 26935927

2

Treatment of metastatic renal cell cancer with sunitinib during chronic hemodialysis.

Zastrow S, Froehner M, Platzek I, Novotny V, Wirth MP. Zastrow S, et al. Urology. 2009 Apr;73(4):868-70. doi: 10.1016/j.urology.2008.10.028. Epub 2009 Jan 23. Urology. 2009. PMID: 19167044

3

Immunohistochemical analysis of prognostic protein markers for primary localized clear cell renal cell carcinoma.

Weber T, Meinhardt M, Zastrow S, Wienke A, Fuessel S, Wirth MP. Weber T, et al. Among authors: zastrow s. Cancer Invest. 2013 Jan;31(1):51-9. doi: 10.3109/07357907.2012.749267. Cancer Invest. 2013. PMID: 23327192

4

Analyses of potential predictive markers and survival data for a response to sunitinib in patients with metastatic renal cell carcinoma.

Dornbusch J, Zacharis A, Meinhardt M, Erdmann K, Wolff I, Froehner M, Wirth MP, Zastrow S, Fuessel S. Dornbusch J, et al. Among authors: zastrow s. PLoS One. 2013 Sep 27;8(9):e76386. doi: 10.1371/journal.pone.0076386. eCollection 2013. PLoS One. 2013. PMID: 24086736 Free PMC article.

5

Prognostic impact of urokinase-type plasminogen activator system components in clear cell renal cell carcinoma patients without distant metastasis.

Fuessel S, Erdmann K, Taubert H, Lohse-Fischer A, Zastrow S, Meinhardt M, Bluemke K, Hofbauer L, Fornara P, Wullich B, Baretton G, Magdolen V, Wirth MP, Kotzsch M. Fuessel S, et al. Among authors: zastrow s. BMC Cancer. 2014 Dec 18;14:974. doi: 10.1186/1471-2407-14-974. BMC Cancer. 2014. PMID: 25519168 Free PMC article.

6

Impact of resection margin status after nephron-sparing surgery for renal cell carcinoma.

Berdjis N, Hakenberg OW, Zastrow S, Oehlschläger S, Novotny V, Wirth MP. Berdjis N, et al. Among authors: zastrow s. BJU Int. 2006 Jun;97(6):1208-10. doi: 10.1111/j.1464-410X.2006.06157.x. BJU Int. 2006. PMID: 16686712

7

Whole-body MRI in follow-up of patients with renal cell carcinoma.

Platzek I, Zastrow S, Deppe PE, Grimm MO, Wirth M, Laniado M, Stroszczynski C. Platzek I, et al. Among authors: zastrow s. Acta Radiol. 2010 Jun;51(5):581-9. doi: 10.3109/02841851003724846. Acta Radiol. 2010. PMID: 20429759

8

Expression of the Forkhead transcription factor FOXP1 is associated with tumor grade and Ki67 expression in clear cell renal cell carcinoma.

Toma MI, Weber T, Meinhardt M, Zastrow S, Grimm MO, Füssel S, Wirth MP, Baretton GB. Toma MI, et al. Among authors: zastrow s. Cancer Invest. 2011 Feb;29(2):123-9. doi: 10.3109/07357907.2010.535059. Epub 2011 Jan 6. Cancer Invest. 2011. PMID: 21210727

9

Surgery for renal cell cancer extending into the inferior vena cava - evaluation of survival and perioperative complications using a standardized classification system.

Zastrow S, Leike S, Oehlschläger S, Grimm MO, Wirth M. Zastrow S, et al. BJU Int. 2011 Nov;108(9):1439-43. doi: 10.1111/j.1464-410X.2011.10289.x. Epub 2011 Jun 28. BJU Int. 2011. PMID: 21711433

10

Advances in renal cell carcinoma treatment.

Grimm MO, Wolff I, Zastrow S, Fröhner M, Wirth M. Grimm MO, et al. Among authors: zastrow s. Ther Adv Urol. 2010 Feb;2(1):11-7. doi: 10.1177/1756287210364959. Ther Adv Urol. 2010. PMID: 21789079 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

67 results

Search Page

Filters